AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 23,000
+800 (3.60%)
At close: Jul 18, 2025, 3:30 PM KST
AprilBio Company Description
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases.
The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.
AprilBio Co.,Ltd.
| Country | South Korea |
| Founded | 2013 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Sang-Hoon Cha |
Contact Details
Address: Room 602, Building B Chuncheon-si, 24341 South Korea | |
| Website | aprilbio.com |
Stock Details
| Ticker Symbol | 397030 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Sang-Hoon Cha | Chief Executive Officer |
| Jin-Taek Kim | Chief Financial Officer |